2019年7月31日 ASLAN Pharmaceuticals to present new data on Varlitinib at European Society for Medical Oncology Congress
2019年7月10日 亚狮康执行长Carl Firth博士将于2019年9月8-10日于纽约举办之H.C. Wainwright 21st Annual Healthcare Conference发表简报
2019年5月10日 ASLAN Pharmaceuticals’ varlitinib selected by leading Korean gastric cancer group for study in second-line gastric cancer
2019年4月29日 ASLAN Pharmaceuticals reports first quarter 2019 financial results and provides corporate update
2019年3月22日 ASLAN Pharmaceuticals reports Fourth Quarter and Full Year 2018 Financial Results and provides Corporate Update
2019年3月11日 ASLAN Pharmaceuticals signs new agreement with BioGenetics for commercialisation of ASLAN003 in South Korea
2019年2月27日 ASLAN Pharmaceuticals to partner with Biogenetics on commercialisation of varlitinib in South Korea
2019年1月30日 ASLAN Pharmaceuticals announces strategic prioritisation of clinical development programs and corporate restructuring
2019年1月23日 ASLAN announces publication of new pre-clinical data demonstrating the activity of varlitinib in TNBC cell lines